Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (171-180 of 260) with videos related to

Pageof 26
Sort By:
Cancer Research|April 1, 1993
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.
Surgical Oncology|January 1, 1993
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposideP Lindnér, D D Heath, D R Shalinsky, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cellsE J Katz, J S Vick, K M Kling, et al.
British Journal of Cancer|September 1, 1994
Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell linesE F McClay, K D Albright, J A Jones, et al.
International Journal of Cancer|December 2, 1993
Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesE F McClay, K D Albright, J A Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Uridine pharmacokinetics in cancer patientsT C Chan, M Markman, C E Pfeifle, et al.
British Journal of Cancer|September 20, 2000
Identification of genes differentially expressed in association with acquired cisplatin resistanceA Johnsson, I Zeelenberg, Y Min, et al.
Cancer Research|April 1, 1993
Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoamS Kim, S Khatibi, S B Howell, et al.
Archives of Neurology|March 1, 1993
Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I studyM C Chamberlain, S Khatibi, J C Kim, et al.
Cancer Research|July 1, 1997
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sitesJ A Jones, K D Albright, R D Christen, et al.
Pageof 26

Showing results (171-180 of 260) with videos related to

Sort By:
Pageof 26
Cancer Research|April 1, 1993
Tamoxifen modulation of cisplatin sensitivity in human malignant melanoma cellsE F McClay, K D Albright, J A Jones, et al.
Surgical Oncology|January 1, 1993
Regional lymphatic drug exposure following intraperitoneal administration of 5-fluorouracil, carboplatin, and etoposideP Lindnér, D D Heath, D R Shalinsky, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Effect of topoisomerase modulators on cisplatin cytotoxicity in human ovarian carcinoma cellsE J Katz, J S Vick, K M Kling, et al.
British Journal of Cancer|September 1, 1994
Tamoxifen delays the development of resistance to cisplatin in human melanoma and ovarian cancer cell linesE F McClay, K D Albright, J A Jones, et al.
International Journal of Cancer|December 2, 1993
Tamoxifen modulation of cisplatin cytotoxicity in human malignanciesE F McClay, K D Albright, J A Jones, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Uridine pharmacokinetics in cancer patientsT C Chan, M Markman, C E Pfeifle, et al.
British Journal of Cancer|September 20, 2000
Identification of genes differentially expressed in association with acquired cisplatin resistanceA Johnsson, I Zeelenberg, Y Min, et al.
Cancer Research|April 1, 1993
Prolongation of drug exposure in cerebrospinal fluid by encapsulation into DepoFoamS Kim, S Khatibi, S B Howell, et al.
Archives of Neurology|March 1, 1993
Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I studyM C Chamberlain, S Khatibi, J C Kim, et al.
Cancer Research|July 1, 1997
Synergy between tamoxifen and cisplatin in human melanoma cells is dependent on the presence of antiestrogen-binding sitesJ A Jones, K D Albright, R D Christen, et al.
Pageof 26